Recalls & Warnings February 20, 2025 Maker of Zicam Agrees to Pay $6 Million to Settle Lawsuit Over Claims to Shorten Colds The maker of Zicam Cold Remedy products, Church & Dwight Co., Inc., has agreed to pay up to $6 million to settle a class action lawsuit that charged it with promoting the products to reduce the severity of cold symptoms and reduce the duration of colds without reliable scientific evidence
Studies show GH plays a major role in reducing visceral fatthe dangerous belly fat linked to metabolic disease
Cagrilintide is being studied both independently and in combination with GLP-1 analogs like Semaglutide (Enebo et al.)
Network-based medicine presents a robust strategy for discovering such agents, which can address the intricate mechanisms underlying AD
GHK-Cu is a peptide complex formed by the tripeptide glycyl-L-histidyl-L-lysine bound to copper ions
pHPMA-coating induced the facilitated mucus permeation and adhesion by reducing the potential electrostatic interaction with mucus constituents (Shan et al., 2015)